Loading clinical trials...

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. | Clinical Trials | Clareo Health

UNKNOWNPhase 1/2NCT04291209

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Although many intratympanic agents have been attempted, N-Acetylcysteine (NAC) appears to be the most promising and is a powerful, commonly used anti-oxidant. The goal of this prospective phase 2 rand...

Lead sponsor: Sunnybrook Health Sciences Centre•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Varia Sajeniouk

CONTACT

1-416-480-6100 [email protected]

Related studies

Not Yet Recruiting

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

NCT06929468 · Ototoxic Hearing Loss, Ototoxicity, Drug-Induced, and more

TERMINATEDPhase 4

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

NCT04226456 · Ototoxic Hearing Loss, Ototoxic Hearing Loss, Bilateral, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 6, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE1/PHASE2

Enrollment80

Start dateFeb 2020

Last updatedSep 6, 2023

Condition

Ototoxic Hearing Loss

Locations shown

Odette Cancer Centre, Sunnybrook Health Sciences Centre

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 6, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions